Home » Newsletters » BioWorld Science

BioWorld Science

June 13, 2001

View Archived Issues

Phase II study shows NS-2330 capable of improving cognitive function in Alzheimer's patients

Genentech reacquires rights to growth hormone products from Schwarz

Clinical trials of NMP-66 for early detection of breast cancer open in Germany

Gilead begins phase I study of adefovir dipivoxil in China for treatment of HBV

Role for melatonin in Rx of periodontal disease discussed at IBMS/ECTS meeting

Neotrofin protects against kainic acid-induced neuronal injury in rodent model

NIH awards Direct Therapeutics SBIR grant

Vaxfectin enhances humoral immune response without affecting cell-mediated response to pDNA vaccines

Vasogen and CANVAC enter research alliance for immune modulation therapy

Endovasc studies new topical use of Liprostin

Pediatric pneumococcal conjugate vaccine approved in Canada

Nonviral hemophilia A gene therapy appears feasible according to phase I data

Enrollment in second rubitecan trial completed, triggering milestone payment

E.C. approves Amgen's ARANESP

Biogen's Amevive successfully completes phase III trials

Adenoviral transfer of PTEN as a promising anticancer gene therapy

pHyde, a new target gene in the treatment of prostate cancer

Rapid and progressive response to Elmiron reported in IC patients at AUA meeting

First launch for Myocet, a new breast cancer therapy

Company Profile: BioVex

COX-2 selective antiinflammatory agents in the Yakult Honsha portfolio

New prostaglandin derivatives useful for nephropathies and cardiovascular diseases

Vitamin D derivatives patented by Nisshin Flour Milling

Novel taxanes with improved profile designed at Daiichi

Preparation and methods of use of new uPAR antagonists

Analgesic activity demonstrated for Banyu's new muscarinic M4 receptor agonists

Takeda compounds inhibit testosterone synthesis, useful for sex steroid-dependent disorders

Fujisawa presents new antimicrobial cyclic hexapeptides

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...